• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.09% Nasdaq Up0.98%

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    238.60 0.00(0.00%) Jun 22, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 927   1,237   1,326   2,343  
    Cost of Revenue -   -   -   -  
    Gross Profit 927   1,237   1,326   2,343  
    Operating Expenses
    Research Development38,207  40,637  34,605  39,528  
    Selling General and Administrative21,671  17,662  14,441  12,591  
    Non Recurring -   -   -   -  
    Others222  244  318  537  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (59,173) (57,306) (48,038) (50,313)
    Income from Continuing Operations
    Total Other Income/Expenses Net(169)131  (265)89  
    Earnings Before Interest And Taxes(59,342)(57,175)(48,303)(50,224)
    Interest Expense -   -   -   -  
    Income Before Tax(59,342)(57,175)(48,303)(50,224)
    Income Tax Expense259  490  16  16  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(59,601)(57,665)(48,319)(50,240)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (59,601) (57,665) (48,319) (50,240)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (59,601) (57,665) (48,319) (50,240)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.